Prospective analysis of complications 30 days after outpatient upper endoscopy.
OBJECTIVE
The aim of this study was to compare complication rates reported by patients 30 days after outpatient upper endoscopy with those discussed at our monthly morbidity and mortality conference. We also intended to establish which complications were reported most frequently 30 days after upper endoscopy, and which patients or procedures involved the highest risk.


METHODS
Trained interviewers performed standardized telephone interviews on consecutive outpatients undergoing upper endoscopy over a 1-yr period. Patients were queried regarding potential events related to their upper endoscopy in the 30 days subsequent, including symptoms, emergency room (ER) and/or physician visits, and hospitalizations. The indications, findings, and therapies were reviewed from endoscopic reports.


RESULTS
A total of 473 patients were contacted 30 days after outpatient upper endoscopy and agreed to participate in our study. The most common complications reported by patients at 30 days were sore throat (9.5%) and abdominal discomfort (5.3%). Twelve patients (2.5%) required an ER/physician visit and five patients (1.1%) required hospitalization. The minority of both ER/physician visits (16.7%) and hospitalizations (40%) were discussed at our monthly morbidity and mortality conferences.


CONCLUSIONS
More complications were reported by patients 30 days after outpatient upper endoscopy than were discussed at our monthly morbidity and mortality conferences. The most frequent complications reported by patients were sore throat and abdominal pain. The minority of ER/physician visits and hospitalizations were discussed at our morbidity and mortality conferences.
Zubarik
R
R
Department of Gastroenterology, Georgetown University Hospital, Washington, DC, USA.
Eisen
G
G
Mastropietro
C
C
Lopez
J
J
Carroll
J
J
Benjamin
S
S
Fleischer
D E
DE
D015746:Abdominal Pain / Q000453:epidemiology / Q000209:etiology; D015331:Cohort Studies; D004632:Emergency Medical Services; D016099:Endoscopy, Gastrointestinal / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009819:Office Visits; D010045:Outpatients; D010612:Pharyngitis / Q000453:epidemiology / Q000209:etiology; D011446:Prospective Studies; D013997:Time Factors